Abstract
The paper represents a modern view on the problem of tension-type headache (TTH) in adolescents, which is caused by the following factors: information overload and other types of stress, sleep deprivation, and physical activity deficiency, impaired posture with myogenic trigger points developing. The research covered 64 adolescents aged 14–15 with tension-type headaches: 33 boys and 42 girls (11 boys and 20 girls with frequent episodic tension-type headache (ETTH) and 12 boys and 21 girls with chronic tension-type headache (CTTH)). We assessed accompanying symptoms over the last 6 months according to the Likert scale. All children were prescribed GABA receptor agonist—aminophenylbutyric acid hydrochloride 250 mg three times a day for 3 weeks. The reduction of tension-type headache intensity was assessed by 3-grade scale: “no change,” “significantly reduced,” and “completely stopped”: 0—no, 1—very seldom, 2—often, and 3—permanently. ETTH/CTTH associated symptoms are as follows: (1) difficulty of falling asleep and restless sleep (0.91 ± 0.83/1.54 + 1.26), (2) difficulty of concentrating during the day (0.61 + 0.92/2.04 + 1.21), (3) morning sickness (0.32 + 0.87/1.81 + 1.29), (4) feeling ill in the morning with improvement in the second half of the day (0.17 + 0.57/1 95 + 0.95), (5) meteosensitivity (0.58 + 1.01/1.59 + 1.22), and (6) decrease in physical capability (0.20 + 0.64/1.72 + 0.82). After 3 weeks, the pain in ETTH subgroup completely stopped in 27 children (79%) and significantly reduced in 7 (21%). In CTTH subgroup, the pain completely stopped in 9 children (41%) and significantly reduced in 13 (59%). Associated symptoms of ETTH/CTTH are as follows: (1) difficulty of falling asleep and restless sleep (0.26 + 0.44, p = 0.000093/0.45 + 0.80, p = 0.000224), (2) difficulty of concentrating during the day (0.17 + 0.38, p = 0.003707/0.54 + 0.85; p = 0.000007), (3) morning sickness (0.08 + 0.28, p = 0. 058101/0.77 + 1.06, p = 0.001682), (4) feeling ill in the morning with improvement in the second half of the day (0.08 + 0.28, p = 0.083119/0.27 + 0.45; p = 0.000000), (5) meteosensitivity (0.32 + 0.63, p = 0.010304/1.36 + 1.09, p = 0.021450), and (6) decrease in physical capability (0.058 + 0 23; p = 0.133706 / 0.95 + 1.04, p = 0.005055). Aminophenylbutyric acid hydrochloride (GABA receptor agonist) reduces the intensity of tension-type headache and has a positive effect on associated symptoms. It can be recommended for inclusion into the scheme of tension-type headache treatment in schoolchildren.
Similar content being viewed by others
References
Abu-Arafeh, I., Razak, S., Sivaraman, B., & Graham, C. (2010). Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Developmental Medicine & Child Neurology., 52, 1088–1097.
Blume H. (2012). Pediatric headache: a review. Pediatrics in Review 2012; 33(12): 562–576. https://doi.org/10.1542/pir.33-12-562.
Karli, N., Akgoz, S., Zarifoglu, M., et al. (2006). Clinical characteristics of tension-type headache and migraine in adolescents: a student-based study. Headache, 46(3), 399–412.
Akyol, A., Kiylioglu, N., Aydin, I., et al. (2007). Epidemiology and clinical characteristics of migraine among school children in the Menderes region. Cephalalgia, 27(7), 781–787.
Sillanpaa, M., Piekkala, P., & Kero, P. (1991). Prevalence of headache at preschool age in an unselected child population. Cephalalgia, 11(5), 239–242.
Fearon, P., & Hotopf, M. (2001). Relation between headache in childhood and physical and psychiatric symptoms in adulthood: national birth cohort study. BMJ, 322(7295), 1145.
Bugdayci, R., Ozge, A., Sasmaz, T., et al. (2005). Prevalence and factors affecting headache in Turkish schoolchildren. Pediatrics International, 47(3), 316–322.
Headache Classification Committee of the International Headache Society. (2013). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia, 33(9), 629–808.
Likert, R. (1932). A technique for the measurement of attitudes. Archives of Psychology, 140, 1–55.
Simons, D., Travell, J., Simons, L., & Travell, J. (1999). Myofascial pain and dysfunction. Baltimore: Williams & Wilkins.
Esin, O. R., Esin, R. G., Tukhbatulin, M. G., Nasirtdinova, A. M., & Sakhapova, L. R. (2014). Muscular-arterial nociceptive reflex in patients with primary headaches. Zh Nevrol Psikhiatr Im S.S.Korsakova 2014, 114(1), 13–15.
Rahim, A., & Seffinger, M. (2016). Myofascial trigger point release massage therapy relieves tension-type headaches. The Journal of the American Osteopathic Association., 116(1), 55. https://doi.org/10.7556/jaoa.2016.009
Strine, T. W., Okoro, C. A., McGuire, L. C., & Balluz, L. S. (2006). The associations among childhood headaches, emotional and behavioral difficulties, and health care use. Pediatrics, 117(5), 1728–1735.
Mazzone, L., Vitiello, B., Incorpora, G., & Mazzone, D. (2006). Behavioral and temperamental characteristics of children and adolescents suffering from primary headache. Cephalalgia, 26(2), 194–201.
Derdikman-Eiron, R., Indredavik, M. S., Bratberg, G. H., et al. (2011). Gender differences in subjective well-being, self-esteem and psychosocial functioning in adolescents with symptoms of anxiety and depression: findings from the Nord-Trondelag Health Study. Scandinavian Journal of Psychology, 52, 261–267.
Claar, R. L., Baber, K. F., Simons, L. E., et al. (2008). Pain coping profiles in adolescents with chronic pain. Pain, 140, 368–375.
Greenlee D., van Ness P., Olsen R. (2004). Endogenous inhibitor of GABA binding in mammalian brain. Life Sciences. 1978;22(18):1653–1662. https://doi.org/10.1016/0024-3205(78)90062-0.
Bowery, N., Enna, S., & Olsen, R. Six decades of GABA. Biochemical Pharmacology, 68(8), 1477–1478. https://doi.org/10.1016/j.bcp.2004.07.033
Lapin, I. (2006). Phenibut (β-Phenyl-GABA): a tranquilizer and nootropic drug. CNS Drug Reviews 2006, 7(4), 471–481. https://doi.org/10.1111/j.1527-3458.2001.tb00211.x
Acknowledgements
The reported study was supported by the program of competitive growth of Kazan Federal University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Esin, O.R. Treatment of Tension-Type Headaches in Adolescents (14–15 Years Old): the Efficacy of Aminophenylbutyric Acid Hydrochloride. BioNanoSci. 8, 418–422 (2018). https://doi.org/10.1007/s12668-018-0507-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12668-018-0507-6